Calendar TME Pharma N.V.

Equities

Market Closed - Euronext Paris Other stock markets 16:35:22 26/04/2024 BST			5-day change	1st Jan Change
0.249 ^EUR	+0.20%		-0.99%	+8.26%

04-25	TME Pharma N.V. Reports Earnings Results for the Full Year Ended December 31, 2023	CI
04-23	TME Pharma N.V. Announces 33% of Patients Receiving NOX-A12 in Combination With Bevacizumab and Radiotherapy Achieve Two-Year Survival in GLORIA Phase 1/2 Trial in Brain Cancer	CI

7d3b2834d0.yWwyMp89kdIt99KoRqgrv-lJYibna9lLft4s8nrFYJk.mQEERq5b_ZhisZPnLuMfzYx-J2-zBJI6C6xFk0KrKtyOPntg1mzzuB6niw~4e6b2f18397959eab75a9600e2ac08ce

23/10/2024	Q2 2024 Earnings Release (Projected)
22/04/2025	Q4 2024 Earnings Release (Projected)
22/10/2025	Q2 2025 Earnings Release (Projected)
28/04/2026	Q4 2025 Earnings Release (Projected)

25/04/2024 17:00	Q4 2023 Earnings Release
25/03/2024	Glioblastoma Development Summit
17/03/2024	Bio Europe Spring Conference
18/11/2023 03:30	Society for Neuro Oncology Meeting
27/10/2023 17:00	Q2 2023 Earnings Release
21/10/2023 10:15	European Society for Medical Oncology Congress
29/06/2023 12:30	Annual General Meeting
03/06/2023 19:15	American Society of Clinical Oncology Conference - abstract #2048
01/06/2023	American Society of Clinical Oncology Conference
24/04/2023 17:00	Q4 2022 Earnings Release
30/01/2023 12:30	Extraordinary Shareholders Meeting
22/11/2022 17:00	Investor Meeting - Key Opinion Leader
19/11/2022 00:30	Society for Neuro-Oncology Meeting - Abstract No: CTNI-67
26/10/2022 18:00	Interim 2022 Earnings Release
23/10/2022	BIO Europe Conference
20/09/2022	Sachs Associates Biotech in Europe Forum
08/09/2022	ESMO Congress Conference
29/06/2022 13:00	Annual General Meeting
10/06/2022 13:00	Investor Meeting - Key Opinion Leader
02/06/2022	American Society of Clinical Oncology Meeting

Fiscal Period	December	2019	2020	2021	2022
Net sales Million EUR	Released Forecast Spread	0,00 0,00 -	0,00	0,00 6,60 -	0,03 0,10 -66%
EBITDA Million EUR	Released Forecast Spread	-3,90 -4,95 21.19%	0,00	-13,2 -5,20 -153.87%	-11,9 -16,3 26.77%
EBIT Million EUR	Released Forecast Spread	-3,95 -5,05 21.82%	0,00	-13,3 -5,30 -150.32%	-12,0 -16,3 26.2%
Earnings before Tax (EBT)	Released Forecast Spread	0,00 0,00 -	0,00	0,00 0,00 -	0,00 0,00 -
Net income Million EUR	Released Forecast Spread	-0,86 -5,50 84.35%	-10,4	0,00 0,00 -	0,00 0,00 -
EPS EUR	Released Forecast Spread	0,00 0,00 -	-32,0	0,00 0,00 -	0,00 0,00 -
Announcement Date		22/04/20	28/04/21	22/04/22	24/04/23

28/04/2024	BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q1 2024 Earnings Release (Projected)
28/04/2024	SINO BIOLOGICAL,INC.: Q1 2024 Earnings Release
28/04/2024	JOINN LABORATORIES(CHINA)CO.,LTD.: Q1 2024 Earnings Release
28/04/2024	MORPHOSYS AG: Q1 2024 Earnings Release
29/04/2024 21:05	QIAGEN N.V.: Q1 2024 Earnings Release
29/04/2024	CRISPR THERAPEUTICS AG: Q1 2024 Earnings Release (Projected)
30/04/2024	DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024	PROTAGONIST THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024	EDITAS MEDICINE, INC.: Q1 2024 Earnings Release (Projected)
30/04/2024	AZENTA, INC.: Q2 2024 Earnings Release (Projected)

26/04/2024	GEMPHARMATECH CO., LTD.: Q1 2024 Earnings Release
26/04/2024	GEMPHARMATECH CO., LTD.: Q4 2023 Earnings Release
26/04/2024 06:00	BB BIOTECH AG: Q1 2024 Earnings Release
25/04/2024	BIDE PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024	PHARMARESOURCES (SHANGHAI) CO., LTD.: Q1 2024 Earnings Release
25/04/2024	HINOVA PHARMACEUTICALS INC.: Q1 2024 Earnings Release (Projected)
25/04/2024	BEIJING SUN-NOVO PHARMACEUTICAL RESEARCH CO., LTD.: Q4 2023 Earnings Release
25/04/2024	CHEMPARTNER PHARMATECH CO., LTD.: Q4 2023 Earnings Release
25/04/2024 12:00	MORPHIC HOLDING, INC.: Q1 2024 Earnings Release
25/04/2024 07:00	PURETECH HEALTH PLC: Q4 2023 Earnings Release